GEN Exclusives

More »

New Products

Whether you are searching for a DNA purification kit or outfitting a cGMP facility, GEN’s comprehensive new product database is your first and only stop. Conveniently categorized and searchable, the database covers the latest innovations from industry-leading suppliers.

Informatics

  • Page 1 of 1 (4 items) 1 

Chemical Structure Searching Sofware

PerkinElmer

Based on the ChemDraw® drawing tool, the chemical intelligence in Lead Discovery 5.1 provides scientists using TIBCO Spotfire® software with chemical structure searching and visualization. Users can filter experimental datasets by chemica...

Bioinformatics Software Platform

Life Technologies

Vector NTI® Express Designer is designed for molecular biology, metabolic engineering, genetic engineering, and synthetic biology professionals who want to design, assemble, and order synthetic genetic parts. An extension of the Vector NTI sof...

Open-Source Tools for Representing Macromolecules

Pistoia Alliance

The Hierarchical Editing Language for Macromolecules (HELM) enables the representation of a range of biomolecules (such as proteins, nucleotides, and antibody-drug conjugates) whose size and complexity render existing small molecule and sequence-ba...

LC/MS Data Visualization Software

Thermo Fisher Scientific

FreeStyle™ 1.0 is a data visualization software for information rendering, method development, and data-quality assessment. It also provides report-writing capabilities. FreeStyle 1.0 is designed to be compatible with both low- and high-resolution ...

  • Page 1 of 1 (4 items) 1 

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?